Ethylene Diamine Tetra Acetic Acid Tris

Verify with FDA CVM →

24 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
24
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Ethylene Diamine Tetra Acetic Acid Tris

Administration Routes

UnknownAuricular (Otic)Other

Species Affected

Dog 22
Cat 2

Most Affected Breeds

Retriever - Labrador 3
Shepherd Dog - German 2
Pug 2
Shih Tzu 2
Retriever - Golden 2
Spaniel - Cocker English 1
Terrier - West Highland White 1
Dachshund - Miniature 1
Domestic Shorthair 1
Maltese 1

Most Reported Reactions

Lack of efficacy - NOS 10
Ear discharge 6
Ataxia 4
Deafness 3
Lethargy (see also Central nervous system depression in 'Neurological') 3
Other abnormal test result NOS 3
Ear canal inflammation 3
Ear pain 3
Impaired hearing 2
Polydipsia 2
Emesis (multiple) 2
Dry eye 2

Outcome Breakdown

Outcome Unknown
14 (58.3%)
Recovered/Normal
8 (33.3%)
Ongoing
2 (8.3%)

Data Summary

Metric Value
Total adverse event reports 24
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 18
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ethylene Diamine Tetra Acetic Acid Tris Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 24 adverse event reports referencing Ethylene Diamine Tetra Acetic Acid Tris, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ethylene Diamine Tetra Acetic Acid Tris. Reported administration routes include Unknown, Auricular (Otic), Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ethylene Diamine Tetra Acetic Acid Tris reports are Dog (22 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (3), Shepherd Dog - German (2), Pug (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ethylene Diamine Tetra Acetic Acid Tris are Lack of efficacy - NOS (10), Ear discharge (6), Ataxia (4), Deafness (3). Of the 24 reports with a coded outcome, Outcome Unknown is the leading category at 58.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ethylene Diamine Tetra Acetic Acid Tris.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial